A nine-year surveillance of healthcare-associated infections in a pediatric Intensive Care Unit: epidemiology, pathogens, and antimicrobial resistance trends
DOI:
https://doi.org/10.3855/jidc.22442Keywords:
pediatric intensive care unit, healthcare-associated infections, antimicrobial resistance, Gram-negative bacteria, bloodstream infections, infection controlAbstract
Introduction: Healthcare-associated infections (HAIs) remain a major cause of morbidity and mortality in pediatric intensive care units (PICUs), particularly in the context of increasing antimicrobial resistance. This study aimed to evaluate the incidence of HAIs, causative microorganisms, antimicrobial resistance patterns, and temporal trends over a nine-year period in the PICU of a tertiary care hospital.
Methodology: HAI data obtained through active surveillance between January 1, 2016, and December 31, 2024, were retrospectively analyzed. Patients who developed HAIs during their PICU stay were included. Diagnoses were established according to the National Healthcare-Associated Infections Surveillance Network (UHESA) criteria adapted from CDC definitions. Microorganisms were identified using the automated VITEK® 2 system (bioMérieux), and antimicrobial susceptibility testing was interpreted according to EUCAST criteria. Data were evaluated by calendar year and in three-year intervals.
Results: No statistically significant change in HAI incidence was observed over the nine-year period (p = 0.56). Gram-negative bacteria were the most frequently isolated pathogens, particularly Klebsiella pneumoniae and Pseudomonas aeruginosa. Among Gram-positive organisms, Staphylococcus aureus and coagulase-negative staphylococci predominated, while Candida species were the most common fungal isolates. The mortality rate among patients with HAIs was 44.7%, markedly higher than the overall PICU mortality rate (1.72%). Resistance rates increased notably, especially for carbapenems and colistin, whereas resistance to linezolid and vancomycin remained limited.
Conclusions: HAIs continue to represent a major clinical challenge in PICUs. Increasing resistance among Gram-negative pathogens highlights the urgent need for strengthened infection control strategies, continuous surveillance, and effective antimicrobial stewardship programs.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Eren Çağan, Şeyma Nur KARATAŞ, Begüm Bodur, Abdullah Taşdelen, Nevin Kılıç

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

